Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies to prevent or treat metastatic disease are still inadequate although great progress has been made in treating early-stage breast cancer. Cancer stem-like cells (CSCs) that are endowed with high plasticity and sel...
Main Authors: | Maria Laura De Angelis, Federica Francescangeli, Ann Zeuner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/10/1569 |
Similar Items
-
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
by: Maria Laura De Angelis, et al.
Published: (2019-07-01) -
COVID-19: a potential driver of immune-mediated breast cancer recurrence?
by: Federica Francescangeli, et al.
Published: (2020-10-01) -
Transcriptomic Profiling Reveals Novel Candidate Genes and Signalling Programs in Breast Cancer Quiescence and Dormancy
by: Lewis A. Quayle, et al.
Published: (2021-08-01) -
Cellular dormancy in minimal residual disease following targeted therapy
by: Jason R. Ruth, et al.
Published: (2021-06-01) -
Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer
by: Rana Jahanban-Esfahlan, et al.
Published: (2019-08-01)